Skip to main content

Experience of the Eliava Institute in bacteriophage therapy

This is a preview of subscription content, access via your institution.

References

  • Alavidze Z, Kutateladze M. Bacteriophage therapy. 2001. New York: Academic Press, pp. 89–92.

    Google Scholar 

  • Kutateladze M, Adamia R. 2008. Medicine et Maladies Infectiouses, 38: 426–430.

    Article  CAS  Google Scholar 

  • Kutateladze M, Adamia R. 2010. Trends Biotechnol, 28: 591–595.

    Article  CAS  PubMed  Google Scholar 

  • Fitzgerald-Hughes D, Bolkvadze D, Balarjishvili N, et al. 2014. J Antimicrob Chemoth, 69:1148–1150.

    Article  CAS  Google Scholar 

  • Kutter E, Borysowski J, Miedzybrodzki R, et al. Norfolk: Caister Academic Press, pp. 257–288.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mzia Kutateladze.

Additional information

ORCID: 0000-0002-7566-7278

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kutateladze, M. Experience of the Eliava Institute in bacteriophage therapy. Virol. Sin. 30, 80–81 (2015). https://doi.org/10.1007/s12250-014-3557-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-014-3557-0

Keywords

  • Phage Therapy
  • VIROLOGICA SINICA
  • Quality Control Production
  • Resistant Bacterial Strain
  • Phage Preparation